- Global Pharma News & Resources

Percutaneous Coronary Intervention Market is expected to reach a value of USD 15,205.4 million by 2023

Global Percutaneous Coronary Intervention Market is expected to reach a value of USD 15,205.4 million by 2023 at an augmenting CAGR of 7.10%.

The global percutaneous coronary intervention market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2017 to 2023. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2017 to 2023.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global percutaneous coronary intervention market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2017 and the growth rate of the global percutaneous coronary intervention market?

What is the market drivers, restrains, opportunities governing the global percutaneous coronary intervention market?

Which are the largest and the fastest growing segments in the global percutaneous coronary intervention market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@

Percutaneous coronary intervention (PCI) is a procedure used to treat the narrowing of coronary arteries. In this procedure, a catheter is used to place a small structure, i.e., a stent to open blood vessels in the heart that have been narrowed owing to plaque build-up. Factors such as the growing prevalence of cardiac diseases, the rising preference for minimally invasive procedures, and growing geriatric population are anticipated to propel the growth of the market over the forecast period.

Factors such as the rising prevalence of heart diseases and increasing preference for minimally invasive procedures are expected to fuel the demand for percutaneous coronary intervention. The increasing geriatric population is also propelling the growth of the market. However, the risk of infection and stringent government regulations are the major challenges for the market.

The global market for percutaneous coronary intervention has been segmented on the basis of product type, end user, and region. On the basis of product type, the market has been divided into coronary stents, PTCA catheters, and coronary guidewire and accessories. Coronary stents are further sub-segmented into drug-eluting stents, bare metal stents, and bioresorbable vascular scaffolds. PTCA catheters are further sub-segmented into balloon catheter and guiding catheter. By accessories, the product type segment is further categorized into inflation devices, torquer, RHV (Y-connector), control syringe, manifold, extension line, and others.
Based on end user, the market has been divided into hospitals and specialty clinics, ambulatory surgical centers, research and academic institutes, and others.

The global percutaneous coronary intervention market accounted for USD 8,679.1 million in 2015 and is expected to register a CAGR of 7.10 % during the forecast period.

Key Players

Some of the key players for the global percutaneous coronary intervention market are Abbott, ASAHI INTECC Company Limited, B. Braun Melsungen AG, Biosensors International Group, Ltd., BIOTRONIK, Boston Scientific Corporation, C. R. Bard, Inc, Comed B.V., Cook, Cordis, Medtronic Plc, Meril Lifesciences Pvt. Ltd, Merit Medical System, Terumo Corporation, and others.

Study Objectives

To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the global percutaneous coronary intervention market
To provide insights into factors influencing and affecting market growth
To provide historical, current, and forecast revenue of market segments based on product type and end user
To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
To provide economic factors, technology trends, and market trends that influence the global percutaneous coronary intervention market

Target Audience

Global percutaneous coronary intervention solution providers, manufacturers, and suppliers
Research and development (Ramp;D) companies
Market research and consulting service providers
Academic institutes and universities
Key Findings

The global percutaneous coronary intervention market is expected to reach a value of USD 15,205.4 million by 2023 at a CAGR of 7.10%.
On the basis of product type, the coronary stents segment is projected to be largest, registering a CAGR of 7.81% during the forecast period.
By end user, the hospitals and clinics segment is expected to be the largest at USD 6,680.0 million by 2023.
On the basis of region, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas market is expected to be the largest at an estimated value of USD 6,068.7 million by 2023.
Asia-Pacific is projected to be the fastest-growing market at a CAGR of 8.14% from 2018 to 2023.

Regional Analysis

North America
South America

Western Europe
Rest of Europe
Eastern Europe

South Korea
Rest of Asia-Pacific

Middle East amp; Africa
Middle East

Few Significant from Table Of Contents

Global Percutaneous Coronary Intervention Market Research Report Forecast to 2023

1 Report Prologue

2 Executive Summary

3 Introduction
3.1 Definition
3.2 Scope of the Study
3.3 Assumptions amp; Limitations
3.4 Market Structure

4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model

5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Rising prevalence of heart diseases
5.2.2 Increasing preference for minimally invasive procedures
5.2.3 Increasing geriatric population
5.3 Restraints
5.3.1 Risk of infection
5.3.2 Stringent government regulations
5.4 Opportunities
5.4.1 Favorable Reimbursement Scenario

6 Market Factor Analysis
6.1 Value Chain Analysis
6.1.1 Research and Development
6.1.2 Manufacturing
6.1.3 Distribution amp; Sales
6.1.4 Post-Sales Monitoring
6.2 Porterrsquo;s Five Forces Model
6.2.1 Bargaining Power of Suppliers
6.2.2 Bargaining Power of Buyers
6.2.3 Threat of New Entrants
6.2.4 Threat of Substitutes
6.2.5 Intense Rivalry
6.3 Investment Opportunity Analysis
6.4 Pricing Analysis
6.5 Market Volume by Product Type

7 Global Percutaneous Coronary Intervention Market by Product Type
7.1 Overview
7.2 Coronary Stents
7.3 PTCA Catheters
7.4 Coronary Guidewire
7.5 Accessories

8 Global Percutaneous Coronary Intervention Market by End-user
8.1 Overview
8.2 Hospitals amp; Specialty Clinics
8.3 Ambulatory Surgical Centers
8.4 Research and Academic Institutes
8.5 Others

9 Global Percutaneous Coronary Intervention Market by Region
9.1 Overview
9.2 Americas
9.2.1 North America US Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe Germany France UK Italy Spain Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 Rest of Asia-Pacific
9.5 Middle East amp; Africa
9.5.1 Middle East
9.5.2 Africa

10 Competitive Landscape
10.1 Introduction
10.2 Company Market Share Analysis

11 Company Profile
11.1 Abbott
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products Offering
11.1.4 SWOT Analysis
11.1.5 Key Developments
11.1.6 Key strategy
11.2 ASAHI INTECC Company Limited
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Key Developments
11.2.4 SWOT Analysis
11.2.5 Key Strategy
11.3 B. Braun Melsungen AG
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products Offering
11.3.4 SWOT Analysis
11.3.5 Key Developments
11.3.6 Key strategy
11.4 Biosensors International Group, Ltd.
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products Offering
11.4.4 SWOT Analysis
11.4.5 Key Developments
11.4.6 Key strategy
11.5.1 Company Overview
11.5.2 Products Offering
11.5.3 SWOT Analysis
11.5.4 Key Developments
11.5.5 Key strategy
11.6 Boston Scientific Corporation
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offering
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 C. R. Bard, Inc.
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offering
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 Comed B.V.
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offering
11.8.4 SWOT Analysis
11.8.5 Key Developments
11.8.6 Key Strategy
11.9 Cook
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offering
11.9.4 SWOT Analysis
11.9.5 Key Developments
11.9.6 Key Strategy
11.1 Cordis
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offering
11.10.4 SWOT Analysis
11.10.5 Key Development
11.10.6 Key Strategy
11.11 Medtronic Plc
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Products Offering
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.11.6 Key Strategy
11.12 Meril Lifesciences Pvt. Ltd
11.12.1 Company Overview
11.12.2 Financial Overview
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.12.6 Key Strategy
11.13 Merit Medical System
11.13.1 Company Overview
11.13.2 Financial Overview
11.13.3 Products Offering
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.13.6 Key Strategy
11.14 Terumo Corporation
11.14.1 Company Overview
11.14.2 Financial Overview
11.14.3 Products Offering
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.14.6 Key Strategy

12 Appendix
12.1 Discussion Blue Print

Quick Buy This Premium Report From Here:

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making a purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


Email: | +1 407 915 4157

Editor Details

Last Updated: 28-Jun-2019